16:45 EDT Terns Pharmaceuticals (TERN) files $300M mixed securities shelf
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TERN:
- Biotech Alert: Searches spiking for these stocks today
- Terns Pharmaceuticals management to meet with Oppenheimer
- Promising Clinical Trials and Strong Financials Drive Buy Rating for Terns Pharmaceuticals
- Terns Pharmaceuticals Reports 2024 Progress and Outlook
- Terns Pharmaceuticals: Promising Investment with Strong Financials and Strategic Developments